IPO Report: Sagimet Biosciences gives going public a second chance under new CEO
IPO Report: Sagimet Biosciences gives going public a second chance under new CEO
182
views
Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the SEC late Friday.
Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the SEC late Friday.

Comments

https://stocktradingwebsites.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!